{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:20Z","timestamp":1787003720391,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Fund Project of Zunyi Science and Technology\nBureau","award":["2022-228"],"award-info":[{"award-number":["2022-228"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06808-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:14:44Z","timestamp":1751382884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: SIAH2-AS1 stimulates breast cancer cell proliferation and migration via the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6808_CR1","first-page":"291","volume":"9","author":"Z Nourolahzadeh","year":"2020","unstructured":"Nourolahzadeh, Z., Houshmand, M., Mohammad, F. M. & Ghorbian,\nS. Correlation between Lsp1 (Rs3817198) and casc (Rs4784227) polymorphisms and\nthe susceptibility to breast Cancer. Rep. Biochem. Mol.\nBiol.\n9, 291\u2013296 (2020).","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"6808_CR2","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.1016\/j.pharmthera.2020.107558","volume":"212","author":"H Liu","year":"2020","unstructured":"Liu, H., Dilger, J. P. & Lin, J. Effects of local anesthetics\non cancer cells. Pharmacol. Ther.\n212, 107558 (2020).","journal-title":"Pharmacol. Ther."},{"key":"6808_CR3","first-page":"1","volume":"130","author":"MB Nierengarten","year":"2024","unstructured":"Nierengarten, M. B. Cancer statistics 2024: deaths drop, incidences\nincrease, prevention needed. Cancer\n130, 1 (2024).","journal-title":"Cancer"},{"key":"6808_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","volume":"23","author":"C Klein","year":"2024","unstructured":"Klein, C., Brinkmann, U., Reichert, J. M. & Kontermann, R. E.\nThe present and future of bispecific antibodies for cancer therapy. Nat. Rev. Drug Discov. 23, 301\u2013319 (2024).","journal-title":"Nat. Rev. Drug Discov"},{"key":"6808_CR5","doi-asserted-by":"publisher","first-page":"e22427","DOI":"10.1016\/j.heliyon.2023.e22427","volume":"9","author":"M Ghorbian","year":"2023","unstructured":"Ghorbian, M. & Ghorbian, S. Usefulness of machine learning and\ndeep learning approaches in screening and early detection of breast cancer.\nHeliyon\n9, e22427 (2023).","journal-title":"Heliyon"},{"key":"6808_CR6","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates\nof incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.\n74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"6808_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin, D., Thomas, A. & Teicher, B. A. Cancer treatments:\npast, present, and future. Cancer Genet.\n286\u2013287, 18\u201324 (2024).","journal-title":"Cancer Genet."},{"key":"6808_CR8","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/nu11071514","volume":"11","author":"P de Cicco","year":"2019","unstructured":"de Cicco, P. et al. Nutrition and breast cancer: a literature\nreview on prevention,\u00a0treatment and recurrence. Nutrients\n11, 1514 (2019).","journal-title":"Nutrients"},{"key":"6808_CR9","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/S1470-2045(18)30511-4","volume":"19","author":"RI Cutress","year":"2018","unstructured":"Cutress, R. I. et al. Opportunities and priorities for breast\nsurgical research. Lancet Oncol.\n19, e521\u2013e533 (2018).","journal-title":"Lancet Oncol."},{"key":"6808_CR10","doi-asserted-by":"publisher","first-page":"103680","DOI":"10.1016\/j.critrevonc.2022.103680","volume":"173","author":"M Entezari","year":"2022","unstructured":"Entezari, M. et al. Non-coding RNAs and macrophage interaction in\ntumor progression. Crit. Rev. Oncol. Hematol.\n173, 103680 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"6808_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbagrm.2015.06.015","volume":"1859","author":"J Liz","year":"2016","unstructured":"Liz, J. & Esteller, M. LncRNAs and MicroRNAs with a role in\ncancer development. Biochim. Biophys. Acta.\n1859, 169\u2013176 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"6808_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1515\/hsz-2014-0201","volume":"395","author":"M Weiss","year":"2014","unstructured":"Weiss, M., Plass, C. & Gerhauser, C. Role of LncRNAs in\nprostate cancer development and progression. Biol.\nChem.\n395, 1275\u20131290 (2014).","journal-title":"Biol. Chem."},{"key":"6808_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergen.2022.11.002","volume":"270\u2013271","author":"\u00c1YG Fonseca","year":"2023","unstructured":"Fonseca, \u00c1. Y. G., Gonz\u00e1lez-Giraldo, Y., Santos, J. G. &\nAristiz\u00e1bal-Pach\u00f3n, A. F. The hsa-miR-516a-5p and hsa-miR-516b-5p MicroRNAs\nreduce the migration and invasion on T98G glioblastoma cell line. Cancer Genet.\n270\u2013271, 12\u201321 (2023).","journal-title":"Cancer Genet."},{"key":"6808_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2024.05.002","volume":"286\u2013287","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. SP1-induced circ_0017552 modulates colon cancer cell\nproliferation and apoptosis via up-regulation of NET1. Cancer Genet.\n286\u2013287, 1\u201310 (2024).","journal-title":"Cancer Genet."},{"key":"6808_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-022-01539-3","volume":"21","author":"ST Xue","year":"2022","unstructured":"Xue, S. T. et al. Long non-coding RNA LINC00680 functions as a\nCeRNA to promote esophageal squamous cell carcinoma progression through the\nmiR-423-5p\/PAK6 axis. Mol. Cancer. 21, 69 (2022).","journal-title":"Mol. Cancer"},{"key":"6808_CR16","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1080\/21655979.2022.2050073","volume":"13","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. LINC00244 suppresses cell growth and metastasis in\nhepatocellular carcinoma by downregulating programmed cell death ligand 1.\nBioengineered\n13, 7635\u20137647 (2022).","journal-title":"Bioengineered"},{"key":"6808_CR17","doi-asserted-by":"crossref","unstructured":"Deng, Y., Wu, J. & Li, X. lncRNA RUNDC3A-AS1 regulates\nproliferation and apoptosis of thyroid cancer cells via the miR-151b\/SNRPB axis.\nInt. J. Endocrinol.\u00a02022,\u00a09433434 (2022).","DOI":"10.1155\/2022\/9433434"},{"key":"6808_CR18","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Zadro\u017cna-Nowak, A. & Romanowicz, H. The role of\nIncRNA in the development of tumors, including breast cancer. Int. J. Mol. Sci. \n22,\u00a0(2021).","DOI":"10.3390\/ijms22168427"},{"key":"6808_CR19","doi-asserted-by":"publisher","first-page":"702082","DOI":"10.3389\/fonc.2021.702082","volume":"11","author":"JH Tian","year":"2021","unstructured":"Tian, J. H., Liu, S. H., Yu, C. Y., Wu, L. G. & Wang, L. B. The\nrole of Non-Coding RNAs in breast Cancer drug resistance. Front. Oncol.\n11, 702082 (2021).","journal-title":"Front. Oncol."},{"key":"6808_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.clbc.2022.01.011","volume":"22","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. LncRNA LINC000466 predicts the prognosis and\npromotes the progression of Triple-negative breast Cancer via modulating\nmiR-539-5p. Clin. Breast Cancer. 22, 374\u2013380 (2022).","journal-title":"Clin. Breast Cancer"},{"key":"6808_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/etm.2021.11032","volume":"23","author":"XP Wu","year":"2022","unstructured":"Wu, X. P. et al. Long non-coding RNA GAS6-AS1 enhances breast\ncancer cell aggressiveness by functioning as a competing endogenous RNA of\nmicroRNA-215-5p to enhance SOX9 expression. Exp. Ther.\nMed.\n23, 109 (2022).","journal-title":"Exp. Ther. Med."},{"key":"6808_CR22","doi-asserted-by":"publisher","first-page":"664393","DOI":"10.3389\/fgene.2021.664393","volume":"12","author":"X Su","year":"2021","unstructured":"Su, X. et al. Construction and analysis of the dysregulated CeRNA\nnetwork and identification of risk long noncoding RNAs in breast Cancer.\nFront. Genet.\n12, 664393 (2021).","journal-title":"Front. Genet."},{"key":"6808_CR23","first-page":"0289","volume":"6","author":"Y Tang","year":"2023","unstructured":"Tang, Y. et al. Dissection of FOXO1-Induced LYPLAL1-DT impeding\nTriple-Negative breast Cancer progression via mediating hnRNPK\/\u03b2-Catenin\ncomplex. Res. (Wash D C). 6, 0289 (2023).","journal-title":"Res. (Wash D C)"},{"key":"6808_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/etm.2016.3333","volume":"12","author":"G Chen","year":"2016","unstructured":"Chen, G. et al. Antiosteoporotic effect of Icariin in\novariectomized rats is mediated via the Wnt\/\u03b2-catenin pathway. Exp. Ther. Med.\n12, 279\u2013287 (2016).","journal-title":"Exp. Ther. Med."},{"key":"6808_CR25","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3892\/etm.2017.4128","volume":"13","author":"H Liu","year":"2017","unstructured":"Liu, H. et al. Icariin improves osteoporosis, inhibits the\nexpression of PPAR\u03b3, C\/EBP\u03b1, FABP4 mRNA, N1ICD and jagged1 proteins, and\nincreases Notch2 mRNA in ovariectomized rats. Exp. Ther.\nMed.\n13, 1360\u20131368 (2017).","journal-title":"Exp. Ther. Med."},{"key":"6808_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu, H., Li, Y., Karsidag, M., Tu, T. & Wang, P. Technical and\nbiological biases in bulk transcriptomic data mining for Cancer research.\nJ. Cancer. 16, 34\u201343 (2025).","journal-title":"J. Cancer"},{"key":"6808_CR27","doi-asserted-by":"publisher","first-page":"146325","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"H Liu","year":"2022","unstructured":"Liu, H. & Weng, J. A comprehensive bioinformatic analysis of\ncyclin-dependent kinase 2 (CDK2) in glioma. Gene\n822, 146325 (2022).","journal-title":"Gene"},{"key":"6808_CR28","first-page":"2140","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu, H. & Tang, T. A bioinformatic study of IGFBPs in glioma\nregarding their diagnostic, prognostic, and therapeutic prediction value.\nAm. J. Transl Res.\n15, 2140\u20132155 (2023).","journal-title":"Am. J. Transl Res."},{"key":"6808_CR29","doi-asserted-by":"publisher","first-page":"e0314745","DOI":"10.1371\/journal.pone.0314745","volume":"20","author":"H Liu","year":"2025","unstructured":"Liu, H., Karsidag, M., Chhatwal, K., Wang, P. & Tang, T.\nSingle-cell and bulk RNA sequencing analysis reveals CENPA as a potential\nbiomarker and therapeutic target in cancers. PLoS\nOne. 20, e0314745\n(2025).","journal-title":"PLoS One"},{"key":"6808_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"H Liu","year":"2024","unstructured":"Liu, H., Weng, J., Huang, C. L. & Jackson, A. P. Voltage-gated\nsodium channels in cancers. Biomark. Res.\n12, 70 (2024).","journal-title":"Biomark. Res."},{"key":"6808_CR31","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene\nexpression profiling and interactive analyses. Nucleic\nAcids Res.\n45, W98\u2013w102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"6808_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2017.07.071","volume":"94","author":"Z Wu","year":"2017","unstructured":"Wu, Z. et al. Icaritin induces MC3T3-E1 subclone14 cell\ndifferentiation through Estrogen receptor-mediated ERK1\/2 and p38 signaling\nactivation. Biomed. Pharmacother. 94, 1\u20139 (2017).","journal-title":"Biomed. Pharmacother"},{"key":"6808_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12885-018-4576-2","volume":"18","author":"R Li","year":"2018","unstructured":"Li, R. et al. Effects of local anesthetics on breast cancer cell\nviability and migration. BMC Cancer.\n18, 666 (2018).","journal-title":"BMC Cancer"},{"key":"6808_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cancers12010131","volume":"12","author":"H Liu","year":"2020","unstructured":"Liu, H., Dilger, J. P. & Lin, J. The role of transient receptor\npotential melastatin 7 (TRPM7) in cell viability: A potential target to suppress\nbreast cancer cell cycle. Cancers (Basel)\n12, 131 (2020).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6808_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/cancers13020234","volume":"13","author":"H Liu","year":"2021","unstructured":"Liu, H., Dilger, J. P. & Lin, J. Lidocaine suppresses viability\nand migration of human breast cancer cells: TRPM7 as a target for some breast\ncancer cell lines. Cancers (Basel)\n13(2), 234 (2021).","journal-title":"Cancers (Basel)"},{"key":"6808_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.acc.2021.09.005","volume":"106","author":"YS Zhu","year":"2022","unstructured":"Zhu, Y. S. & Zhu, J. Molecular and cellular functions of long\nnon-coding RNAs in prostate and breast cancer. Adv.\nClin. Chem.\n106, 91\u2013179 (2022).","journal-title":"Adv. Clin. Chem."},{"key":"6808_CR37","doi-asserted-by":"crossref","unstructured":"Shen, S. Yang, D. Yang, Y. Chen, Y. Xiong, J. & Hu, X. A novel\nprognostic ferroptosis-related lncRNA signature associated with immune landscape\nin invasive breast cancer. Dis. Markers.\n\u00a02022,\u00a09168556 (2022).","DOI":"10.1155\/2022\/9168556"},{"key":"6808_CR38","doi-asserted-by":"publisher","first-page":"155188","DOI":"10.1016\/j.prp.2024.155188","volume":"255","author":"M Taheri","year":"2024","unstructured":"Taheri, M. et al. A review on the role of KCNQ1OT1 LncRNA in human\ndisorders. Pathol. Res. Pract.\n255, 155188 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"6808_CR39","doi-asserted-by":"publisher","first-page":"155101","DOI":"10.1016\/j.prp.2024.155101","volume":"254","author":"S Ghafouri-Fard","year":"2024","unstructured":"Ghafouri-Fard, S., Harsij, A., Hussen, B. M., Pourmoshtagh, H.\n& Taheri, M. A review on the role of FOXD2-AS1 in human disorders. Pathol. Res. Pract.\n254, 155101 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"6808_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/ot9.0000000000000060","volume":"10","author":"L Duan","year":"2024","unstructured":"Duan, L. et al. Bioinformatics analysis of the association between\nmiR-942-5p-induced downregulation of PIEZO-type mechanosensitive ion channel\ncomponent 1 and poor prognosis in non-small cell lung cancer mediated by the\nmitogen-activated protein kinase pathway signaling pathway. Oncol. Transl. Med.\n10, 272\u2013280 (2024).","journal-title":"Oncol. Transl. Med."},{"key":"6808_CR41","doi-asserted-by":"publisher","first-page":"1254232","DOI":"10.3389\/fmolb.2023.1254232","volume":"10","author":"H Chi","year":"2023","unstructured":"Chi, H. et al. Unraveling the role of disulfidptosis-related\nLncRNAs in colon cancer: a prognostic indicator for immunotherapy response,\nchemotherapy sensitivity, and insights into cell death mechanisms. Front. Mol. Biosci.\n10, 1254232 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"6808_CR42","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu, H. & Tang, T. Pan-cancer genetic analysis of Cuproptosis\nand copper metabolism-related gene set. Front.\nOncol.\n12, 952290 (2022).","journal-title":"Front. Oncol."},{"key":"6808_CR43","doi-asserted-by":"publisher","first-page":"e1012879","DOI":"10.1371\/journal.pcbi.1012879","volume":"21","author":"AB Stier","year":"2025","unstructured":"Stier, A. B., Bonaiuti, P., Juh\u00e1sz, J., Gross, F. & Ciliberto,\nA. Lncreased risk of slippage upon disengagement of the mitotic checkpoint.\nPLoS Comput. Biol.\n21, e1012879 (2025).","journal-title":"PLoS Comput. Biol."},{"key":"6808_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12935-022-02536-8","volume":"22","author":"P Li","year":"2022","unstructured":"Li, P. et al. LRP11-AS1 promotes the proliferation and migration of\ntriple negative breast cancer cells via the miR-149-3p\/NRP2 axis. Cancer Cell. Int.\n22, 116 (2022).","journal-title":"Cancer Cell. Int."},{"key":"6808_CR45","doi-asserted-by":"publisher","first-page":"394632022110560","DOI":"10.1177\/03946320221105608","volume":"36","author":"J Li","year":"2022","unstructured":"Li, J., Ke, J., Qin, C. L. & Zhu, X. LINC00680 modulates\ndocetaxel resistance in breast cancer via the miR-320b\/CDKL5 axis. Int. J. Immunopathol. Pharmacol.\n36, 3946320221105608 (2022).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"6808_CR46","doi-asserted-by":"crossref","unstructured":"Liu, H., Guo, Z. & Wang, P. Genetic expression in cancer\nresearch: Challenges and complexity. Gene\nReports\n37, (2024).","DOI":"10.1016\/j.genrep.2024.102042"},{"key":"6808_CR47","doi-asserted-by":"crossref","unstructured":"Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A.,\nTeh, M. T. & Waseem, A. Vimentin is at the heart of epithelial mesenchymal\ntransition (EMT) mediated metastasis. Cancers\n(Basel).\n13,\u00a0(2021).","DOI":"10.3390\/cancers13194985"},{"key":"6808_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/0008-5472.CAN-19-3525","volume":"80","author":"F Bunz","year":"2020","unstructured":"Bunz, F. EMT and back again: visualizing the dynamic phenotypes of\nmetastasis. Cancer Res.\n80, 153\u2013155 (2020).","journal-title":"Cancer Res."},{"key":"6808_CR49","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1515\/med-2020-0206","volume":"15","author":"T Jiang","year":"2020","unstructured":"Jiang, T. et al. Trim24 prompts tumor progression via inducing EMT\nin renal cell carcinoma. Open. Med. (Wars).\n15, 1153\u20131162 (2020).","journal-title":"Open. Med. (Wars)"},{"key":"6808_CR50","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.7150\/jca.58049","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie, Y. et al. ADNP prompts the cisplatin-resistance of bladder\ncancer via TGF-\u03b2-mediated epithelial-mesenchymal transition (EMT) pathway.\nJ. Cancer. 12, 5114\u20135124 (2021).","journal-title":"J. Cancer"},{"key":"6808_CR51","doi-asserted-by":"crossref","unstructured":"Greaves, D. & Calle, Y. Epithelial mesenchymal transition (EMT)\nand associated invasive adhesions in solid and haematological tumours. Cells\n11, (2022).","DOI":"10.3390\/cells11040649"},{"key":"6808_CR52","doi-asserted-by":"publisher","first-page":"831366","DOI":"10.3389\/fonc.2022.831366","volume":"12","author":"Y Xu","year":"2022","unstructured":"Xu, Y., Yu, X., Sun, Z., He, Y. & Guo, W. Roles of LncRNAs\nmediating Wnt\/\u03b2-Catenin signaling in HCC. Front.\nOncol.\n12, 831366 (2022).","journal-title":"Front. Oncol."},{"key":"6808_CR53","doi-asserted-by":"publisher","first-page":"855609","DOI":"10.3389\/fonc.2022.855609","volume":"12","author":"X Song","year":"2022","unstructured":"Song, X., Wei, C. & Li, X. The signaling pathways associated\nwith breast Cancer bone metastasis. Front.\nOncol.\n12, 855609 (2022).","journal-title":"Front. Oncol."},{"key":"6808_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cac2.12507","volume":"44","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. LncRNA-CCAT5-mediated crosstalk between\nWnt\/\u03b2-Catenin and STAT3 signaling suggests novel therapeutic approaches for\nmetastatic gastric cancer with high Wnt activity. Cancer\nCommun. (Lond). 44, 76\u2013100\n(2024).","journal-title":"Cancer Commun. (Lond)"},{"key":"6808_CR55","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1111\/jcmm.13522","volume":"22","author":"G Yang","year":"2018","unstructured":"Yang, G. et al. Crosstalk between long non-coding RNAs and\nWnt\/\u03b2-catenin signalling in cancer. J. Cell. Mol.\nMed.\n22, 2062\u20132070 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"6808_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41419-022-04536-y","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. Hypoxia-induced LncRNA RBM5-AS1 promotes\ntumorigenesis via activating Wnt\/\u03b2-catenin signaling in breast cancer. Cell. Death Dis.\n13, 95 (2022).","journal-title":"Cell. Death Dis."},{"key":"6808_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ol.2021.12634","volume":"21","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. Downregulation of long non-coding RNA MR4435-2HG\nsuppresses breast cancer progression via the Wnt\/\u03b2-catenin signaling pathway.\nOncol. Lett.\n21, 373 (2021).","journal-title":"Oncol. Lett."},{"key":"6808_CR58","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.7150\/thno.37892","volume":"9","author":"T Tang","year":"2019","unstructured":"Tang, T. et al. LncCCAT1 promotes breast Cancer stem cell function\nthrough activating WNT\/\u03b2-catenin signaling. Theranostics\n9, 7384\u20137402 (2019).","journal-title":"Theranostics"},{"key":"6808_CR59","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41419-023-06115-1","volume":"14","author":"W Tian","year":"2023","unstructured":"Tian, W. et al. AURKAIP1 actuates tumor progression through\nstabilizing DDX5 in triple negative breast cancer. Cell.\nDeath Dis.\n14, 790 (2023).","journal-title":"Cell. Death Dis."},{"key":"6808_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-1001","volume":"5","author":"Z Chen","year":"2024","unstructured":"Chen, Z. Integration in biomedical science 2024: emerging trends in\nthe Post-Pandemic era. Bio Integr.\n5, 1\u20132 (2024).","journal-title":"Bio Integr."},{"key":"6808_CR61","doi-asserted-by":"publisher","first-page":"167250","DOI":"10.1016\/j.bbadis.2024.167250","volume":"1870","author":"SJ Lee","year":"2024","unstructured":"Lee, S. J. et al. hsa-miR-CHA2, a novel microrna, exhibits\nanticancer effects by suppressing Cyclin E1 in human non-small cell lung cancer\ncells. Biochim. Biophys. Acta Mol. Basis Dis.\n1870, 167250 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"updated-by":[{"DOI":"10.1038\/s41598-026-39606-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000}},{"DOI":"10.1038\/s41598-026-39606-0","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"record-id":"72227"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06808-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:05:16Z","timestamp":1771650316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06808-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6808"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06808-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-39606-0","URL":"https:\/\/doi.org\/10.1038\/s41598-026-39606-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence\nof any commercial or financial relationships that could be construed as a\npotential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The procedures were acknowledged by the Ethics Committee of the\nSecond Affiliated Hospital of Zunyi Medical University approved all procedures\n(KYLL-2022-032) on April 26, 2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"21911"}}